IS2377B - Fæðubótarefni til inngjafar í garnir sem næring utan meltingarvegar eða næring að hluta til um garnir/munn fyrir alvarlega veika sjúklinga, langveikasjúklinga og vannært fólk - Google Patents

Fæðubótarefni til inngjafar í garnir sem næring utan meltingarvegar eða næring að hluta til um garnir/munn fyrir alvarlega veika sjúklinga, langveikasjúklinga og vannært fólk

Info

Publication number
IS2377B
IS2377B IS6815A IS6815A IS2377B IS 2377 B IS2377 B IS 2377B IS 6815 A IS6815 A IS 6815A IS 6815 A IS6815 A IS 6815A IS 2377 B IS2377 B IS 2377B
Authority
IS
Iceland
Prior art keywords
intestinal
patients
supplements
gastrointestinal
administration
Prior art date
Application number
IS6815A
Other languages
English (en)
Other versions
IS6815A (is
Inventor
Kessler Barbara
Riedel Angelika
Suchner Ulrich
Original Assignee
Fresenius Kabi Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fresenius Kabi Deutschland Gmbh filed Critical Fresenius Kabi Deutschland Gmbh
Publication of IS6815A publication Critical patent/IS6815A/is
Publication of IS2377B publication Critical patent/IS2377B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
IS6815A 2000-11-17 2003-05-14 Fæðubótarefni til inngjafar í garnir sem næring utan meltingarvegar eða næring að hluta til um garnir/munn fyrir alvarlega veika sjúklinga, langveikasjúklinga og vannært fólk IS2377B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10057290A DE10057290B4 (de) 2000-11-17 2000-11-17 Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten
PCT/EP2001/013163 WO2002039978A1 (de) 2000-11-17 2001-11-14 Enteral zu verabreichendes supplement zur parenteralen ernährung oder partiellen enteralen/oralen ernährung bei kritisch kranken, chronisch kranken und mangelernährten

Publications (2)

Publication Number Publication Date
IS6815A IS6815A (is) 2003-05-14
IS2377B true IS2377B (is) 2008-07-15

Family

ID=7663817

Family Applications (1)

Application Number Title Priority Date Filing Date
IS6815A IS2377B (is) 2000-11-17 2003-05-14 Fæðubótarefni til inngjafar í garnir sem næring utan meltingarvegar eða næring að hluta til um garnir/munn fyrir alvarlega veika sjúklinga, langveikasjúklinga og vannært fólk

Country Status (28)

Country Link
US (1) US7947303B2 (is)
EP (1) EP1337236B1 (is)
JP (1) JP2004513912A (is)
KR (2) KR100861889B1 (is)
CN (1) CN1477950A (is)
AT (1) ATE272390T1 (is)
AU (2) AU2484802A (is)
BR (1) BRPI0115451B1 (is)
CA (1) CA2429270C (is)
CZ (1) CZ300129B6 (is)
DE (2) DE10057290B4 (is)
DK (1) DK1337236T3 (is)
EE (1) EE05209B1 (is)
ES (1) ES2223015T3 (is)
HR (1) HRP20030395B1 (is)
HU (1) HU228351B1 (is)
IL (2) IL155840A0 (is)
IS (1) IS2377B (is)
MX (1) MXPA03004348A (is)
NO (1) NO333003B1 (is)
NZ (1) NZ525812A (is)
PL (1) PL202031B1 (is)
PT (1) PT1337236E (is)
RU (1) RU2295952C2 (is)
SI (1) SI1337236T1 (is)
SK (1) SK286199B6 (is)
WO (1) WO2002039978A1 (is)
ZA (1) ZA200303722B (is)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10254584A1 (de) * 2002-11-22 2004-06-09 HORST HEIRLER PROJEKTE für Ernährung, Medizin, Ökologie Verwendung von mittelkettigen Triglyceriden (MCT) zur ernährungsphysiologischen Optimierung des Fettsäurenspektrums in einem diätetischen Lebensmittel für Diabetiker
US20070026090A1 (en) * 2003-09-05 2007-02-01 Oren Tirosh Treatment and prevention of inflammatory disease and mitochondrial dysfunction with high dose selenium
NZ546009A (en) * 2003-09-19 2010-02-26 Nutricia Nv Method and composition for preventing multiple organ dysfunction syndrome
DE10349585A1 (de) * 2003-10-24 2005-06-16 Biosyn Arzneimittel Gmbh Spurenelementzusammensetzung für die Ernährung
DE202004015931U1 (de) * 2004-10-13 2005-01-05 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Omega-3-Fettsäuren und Omega-6-Fettsäuren enthaltende Zusammensetzung
US20050148669A1 (en) * 2004-10-21 2005-07-07 Daniel Amato Amino acid esters as nutrient supplements and methods of use
US11077165B2 (en) * 2004-11-09 2021-08-03 Hills Pet Nutrition, Inc. Use of antioxidants for gene modulation
EP1841445A4 (en) * 2004-12-21 2010-06-02 Critical Care Connections Inc THERAPEUTIC NUTRIENT COMPOSITIONS OR COMBINATIONS AND METHODS OF USE
CN104705651B (zh) 2005-04-27 2018-05-29 努特里希亚公司 含脂类和不易消化的糖的营养品
EP1719543A1 (en) * 2005-05-04 2006-11-08 Asan Labs., Ltd. Use of histone deacetylase inhibitors for the treatment of gastrointestinal distress
WO2006127695A2 (en) * 2005-05-23 2006-11-30 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Ascorbic acid conjugates
CN101247735B (zh) * 2005-08-26 2012-02-01 雀巢技术公司 用于肥胖患者的营养
DE102005046237A1 (de) * 2005-09-28 2007-04-05 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Buttersäureester von Kohlenhydraten und Kohlenhydratpolyolen
CA2629683A1 (en) * 2005-11-15 2007-05-24 Entress Ab Medicament for use in connection with cartilage impairment
CA2631220A1 (en) * 2006-01-09 2007-07-19 Nestec S.A. Treatment of stressed patients
BRPI0713642A2 (pt) * 2006-06-14 2012-10-23 Nutricia Nv composição anti-inflamatória, e, uso de uma composição
KR100774816B1 (ko) * 2006-11-21 2007-11-07 동부일렉트로닉스 주식회사 반도체 소자의 ｍｉｍ 커패시터 제조 방법 및 구조
SI2190304T1 (sl) * 2007-09-17 2012-04-30 Nutricia Nv Prehranska formulacija z visoko energijsko vsebnostjo
CA2703042A1 (en) * 2007-10-14 2009-04-23 University Of Florida Research Foundation Inc. Formulation to improve gastrointestinal function
IT1396935B1 (it) 2009-11-26 2012-12-20 Solartium Entpr Ltd Uso di una combinazione per il trattamento delle mucositi indotte da radiazioni o da chemioterapici
BR112012027427A2 (pt) * 2010-04-26 2015-09-15 Nestec Sa composições nutritivas e métodos para a mudança da nutrição parenteral para a nutrição enteral
WO2012130627A1 (en) * 2011-03-31 2012-10-04 Nestec S.A. Nutritional compositions for increasing arginine levels and methods of using same
CN103458891A (zh) 2011-04-13 2013-12-18 味之素株式会社 营养组合物
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
EP2580967A1 (en) * 2011-10-11 2013-04-17 Nestec S.A. Accelerating muscle recovery after immobilization-induced muscle atrophy
US9849144B2 (en) 2013-09-16 2017-12-26 Healios Oncology Nutrition, LLC Glutamine and trehalose compositions
TW201717931A (zh) 2015-06-10 2017-06-01 Ajinomoto Kk 運動誘發性的消化管障礙之改善劑
ES2638195B1 (es) 2016-04-18 2018-08-02 Bioiberica, S.A. Composiciones para la piel
US11623043B2 (en) 2017-05-09 2023-04-11 Baxter International Inc. Parenteral nutrition diagnostic system, apparatus, and method
CN108208177A (zh) * 2017-11-28 2018-06-29 上海交通大学医学院附属新华医院 含丁酸类化合物的组合物及其应用
PL423673A1 (pl) * 2017-12-01 2019-06-03 Lewandowska Agata Kompozycja do podawania doustnego, zastosowanie kompozycji w zapobieganiu i leczeniu mucositis oraz sposób leczenia mucositis
WO2021191469A1 (en) * 2020-03-27 2021-09-30 Basf Se Composition for the treatment of gastro-intestinal dysfunction and/or associated morbidities thereto
US11666548B2 (en) 2020-06-05 2023-06-06 Baxter International Inc. Parenteral nutrition formulation
US20220160669A1 (en) 2020-11-24 2022-05-26 Baxter International Inc. Parenteral nutrition formulation
DE202021102589U1 (de) 2020-12-15 2021-05-28 Marco Lautenschläger Verzehrfertiges, abgefülltes Getränk auf Basis eines natürlichen Mineralwassers
WO2023205635A1 (en) * 2022-04-19 2023-10-26 Vanderbilt University Compositions and methods of treatment for congenital diarrheal disorder
WO2023215458A1 (en) * 2022-05-06 2023-11-09 Ageless Sciences, Inc. Compositions and methods for slowing down aging and extending lifespan
CN116920075B (zh) * 2023-09-15 2024-01-02 潍坊市人民医院(潍坊市公共卫生临床中心) 一种肠内营养液及其制备方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3698912A (en) * 1969-07-01 1972-10-17 Morton Norwich Products Inc Process for making nutrient composition
DE3135849A1 (de) * 1981-09-10 1983-03-17 Dr. Schumacher GmbH & Co KG, 4600 Dortmund Beschichtungsstoff fuer korrosionsschutzzwecke
US4446389A (en) * 1982-03-15 1984-05-01 Ampex Corporation Quadrature tach decoder circuit
CA1285491C (en) * 1985-09-12 1991-07-02 Robert J. Smith Method of treating catabolic dysfunction
ES2007350A6 (es) * 1987-05-29 1989-06-16 Ganadera Union Ind Agro Productos alimenticios enriquecidos con nucleosidos yno nucleotidos para la nutricion infantil y de adultos, y procedimiento para su preparacion.
IL94549A (en) * 1989-06-02 1996-08-04 Brigham & Womens Hospital A pharmaceutical preparation containing glutamine
AU645070B2 (en) * 1990-04-10 1994-01-06 Nb International Technologies Use of short chain fatty acid containing lipids to maintain gastrointestinal integrity and function in patients DO NOT SEAL - SEE LETTER DATED 22.03.94
SE9002732D0 (sv) * 1990-08-24 1990-08-24 Kabivitrum Ab Product containing growth factor
JP2524551B2 (ja) * 1992-02-28 1996-08-14 雪印乳業株式会社 グルタミン含量の高いペプチド組成物、その製造方法及び経腸栄養剤
WO1994014458A1 (en) * 1992-12-23 1994-07-07 Abbott Laboratories Medical foods for the nutritional support of infant/toddler metabolic diseases
US5326569A (en) * 1992-12-23 1994-07-05 Abbott Laboratories Medical foods for the nutritional support of child/adult metabolic diseases
JP4059532B2 (ja) * 1994-08-15 2008-03-12 森永乳業株式会社 腸内細菌の体内移行を阻止するペプチド混合物と、このペプチド混合物を含有する組成物
US5719133A (en) 1994-09-21 1998-02-17 Novartis Nutrition Ag Adolescent dietary composition
JP4011638B2 (ja) * 1994-12-27 2007-11-21 イーエヌ大塚製薬株式会社 経口経腸栄養組成物
US5569680A (en) * 1995-02-13 1996-10-29 Trustees Of The Univ. Of Penna Method of treating inflammatory bowel disease with tributyrin
DE19528461A1 (de) * 1995-08-03 1997-02-06 Braun Melsungen Ag Präparat zur Ernährung
JPH09323979A (ja) * 1996-06-04 1997-12-16 Meiji Milk Prod Co Ltd 核酸を用いた免疫調節組成物
GB9701674D0 (en) * 1997-01-28 1997-03-19 Novartis Nutrition Ag Use of organic compounds
WO1998041216A1 (en) * 1997-03-17 1998-09-24 Tam Yun K Composition for prevention of hepatic steatosis
GB9709082D0 (en) * 1997-05-06 1997-06-25 Ciba Geigy Ag Organic compositions
US5922766A (en) * 1997-07-02 1999-07-13 Acosta; Phyllis J. B. Palatable elemental medical food
EP0891719A1 (en) * 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine
AU2186699A (en) * 1998-02-09 1999-08-23 Meiji Milk Products Co., Ltd. Preventives and remedies for intestinal mucosal disorder
US6369252B1 (en) * 1998-02-26 2002-04-09 The University Of Georgia Research Foundation, Inc. Structured lipids
JP2002524612A (ja) * 1998-09-11 2002-08-06 ダニスコ カルター アメリカ，インコーポレーテッド カロリーが低減された可塑性脂肪組成物
JP2000119180A (ja) * 1998-10-06 2000-04-25 Nisshin Flour Milling Co Ltd 経腸栄養剤
US7115297B2 (en) * 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives

Also Published As

Publication number Publication date
NO20032160L (no) 2003-07-14
CN1477950A (zh) 2004-02-25
US20040097404A1 (en) 2004-05-20
IS6815A (is) 2003-05-14
HUP0301386A3 (en) 2008-04-28
BRPI0115451B1 (pt) 2016-07-19
DK1337236T3 (da) 2004-12-13
IL155840A0 (en) 2003-12-23
RU2295952C2 (ru) 2007-03-27
KR100861889B1 (ko) 2008-10-09
ES2223015T3 (es) 2005-02-16
NO20032160D0 (no) 2003-05-13
HUP0301386A2 (hu) 2003-09-29
PL202031B1 (pl) 2009-05-29
ATE272390T1 (de) 2004-08-15
HRP20030395B1 (en) 2011-10-31
DE10057290B4 (de) 2004-01-08
BR0115451A (pt) 2004-01-06
WO2002039978A1 (de) 2002-05-23
HRP20030395A2 (en) 2005-04-30
CZ300129B6 (cs) 2009-02-18
PL361634A1 (en) 2004-10-04
MXPA03004348A (es) 2003-08-19
AU2002224848B2 (en) 2006-06-15
ZA200303722B (en) 2004-04-16
US7947303B2 (en) 2011-05-24
SK5612003A3 (en) 2003-10-07
DE50103152D1 (de) 2004-09-09
WO2002039978A8 (de) 2002-07-18
NZ525812A (en) 2004-03-26
KR20030069172A (ko) 2003-08-25
IL155840A (en) 2008-11-03
CA2429270A1 (en) 2002-05-23
CA2429270C (en) 2009-08-18
EE200300198A (et) 2003-08-15
PT1337236E (pt) 2004-11-30
EE05209B1 (et) 2009-10-15
EP1337236A1 (de) 2003-08-27
AU2484802A (en) 2002-05-27
SI1337236T1 (en) 2004-12-31
SK286199B6 (sk) 2008-05-06
JP2004513912A (ja) 2004-05-13
HU228351B1 (hu) 2013-03-28
KR20080069280A (ko) 2008-07-25
NO333003B1 (no) 2013-02-11
DE10057290A1 (de) 2002-06-06
EP1337236B1 (de) 2004-08-04
CZ20031337A3 (cs) 2003-09-17

Similar Documents

Publication Publication Date Title
IS2377B (is) Fæðubótarefni til inngjafar í garnir sem næring utan meltingarvegar eða næring að hluta til um garnir/munn fyrir alvarlega veika sjúklinga, langveikasjúklinga og vannært fólk
IL139681A0 (en) Pharmaceutical compositions containing vitamin b6
AU2002224848A1 (en) Supplement to be enterally administered for parenteral nutrition or partial enteral/oral nutrition of the critically ill, the chronically ill and people with malnutrition
US20100152107A1 (en) Long-term feed - cancer patient
TR200100610T2 (tr) Asetil L-karnitin ve alfa-lipoik asit içeren antioksidant bileşim
KR920000324A (ko) 필수 지방산 처리법
MX9205722A (es) Composicion alimenticia enteral contra el cancer
ATE365743T1 (de) Immunverstärkende verbindungen
HUP0002198A2 (hu) L-Karnitin- vagy alkanoil-L-karnitin-magnézium-fumarátot tartalmazó orálisan beadható szilárd készítmények
EP2716167A1 (en) Non-pharmaceutical composition comprising short chain fatty acids
IS2234B (is) Samsetning til að bæla fráhvarfseinkenni og fíkn í áfengi hjá áfengissjúklingum og fyrirbyggja misnotkun áfengis hjá heilbrigðum einstaklingum
AU5634500A (en) Dietary calcium as a supplement to vitamin d compound treatment of multiple sclerosis
JP5118863B2 (ja) 催眠用医薬組成物
CA2408528A1 (en) Creatine salt having enhanced nutritional and therapeutic efficacy and compositions containing same
WO2003002125A3 (en) Combination of aminosugars and cysteine or cysteine derivatives
MY100780A (en) Azumolene dosage form.
DK1208078T3 (da) Ikke-hygroskopiske salte af aktive bestanddele der har terapeutiske og/eller ernæringsmæssige aktiveteter og sammensætninger til oral indgivelse der indeholder disse
CA2551043A1 (en) The use of cystine or cysteine for the prevention and treatment of oxidative stress caused by haemodialysis and of acute or chronic kidney diseases
HK1025562A1 (en) Solid compositions suitable for oral administration comprising l-carnitine choline tartrate
ES2375391B1 (es) Composición de complemento nutricional.
RU2002101613A (ru) Способ коррекции иммуно-и гепатотоксических эффектов циклофосфана